rewirebio.iobenchmarks
Protocol

Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation

Ten feature sets classified cancer vs healthy on the primary paired-end dataset; mean over 10 outer folds.

10 evaluations · 20 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

10 recorded evaluations, 20 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.

View coverage and remaining gaps across all benchmarks

Results

Results are available, but no reviewed comparison panel is linked in this release.

All evaluations

10 evaluations · 20 results. Different protocols are not a single leaderboard.

Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation · Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)

Sorted by AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

All 20 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Zeng et al. 2026 classifier: Combined All Features (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.97 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0227978278651072. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined All Features (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 2 'Combined All Features (1%)', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Combined All Features (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.86 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.0981509647480165 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined All Features (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 2 'Combined All Features (1%)', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Combined All Features (5%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.932 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0424929753478305. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined All Features (5%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 3 'Combined All Features (5%)', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Combined All Features (5%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.789 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.107405582907328 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined All Features (5%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 3 'Combined All Features (5%)', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: End MotifsProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.93 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0519161667413912. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

End Motifs on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 7 'End Motifs', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: End MotifsProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.826 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.136261133071318 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

End Motifs on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 7 'End Motifs', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Fragment RatioProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.923 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0705965005812822. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragment Ratio on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 8 'Fragment Ratio', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Fragment RatioProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.795 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.193024274189439 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragment Ratio on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 8 'Fragment Ratio', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Insert SizeProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.748 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0974579710205907. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Insert Size on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 9 'Insert Size', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Insert SizeProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.283 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.19494005154084 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Insert Size on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 9 'Insert Size', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: MethylationProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.986 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0209780603284754. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Methylation on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 10 'Methylation', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: MethylationProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.949 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.0870136746761039 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Methylation on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 10 'Methylation', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.938 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0401311333432108. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Motif + Methylation (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 4 'Combined Motif + Methylation (1%)', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.773 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.14899523978531 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Motif + Methylation (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 4 'Combined Motif + Methylation (1%)', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.974 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0242400530902103. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Motif + Methylation + Ratios (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 5 'Combined Motif + Methylation + Ratios (1%)', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.896 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.0857671794470052 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Motif + Methylation + Ratios (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 5 'Combined Motif + Methylation + Ratios (1%)', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Nucleosome PeakProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.689 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.1141088789247. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Nucleosome Peak on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 11 'Nucleosome Peak', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Nucleosome PeakProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.397 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.143496781034909 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Nucleosome Peak on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 11 'Nucleosome Peak', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Combined Ratios + Methylation (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.961 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0300613681834156. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Ratios + Methylation (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 6 'Combined Ratios + Methylation (1%)', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Combined Ratios + Methylation (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.857 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.0828537049838524 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Ratios + Methylation (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 6 'Combined Ratios + Methylation (1%)', column B 'mean_sens99'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Methods and evaluation design

Procedure, tasks and evaluated configurations

Recorded evaluations

Each evaluation records what was tested and under which conditions.

Baseline coverage

Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.

0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.

No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.

Author-reported evaluations
10

Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.

Null control

Proposed control: requires review

Training-set class prior where supervised fitting is permitted

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Conventional reference

Proposed control: requires review

Regularised classifier on simple permitted features, or protocol's conventional reference

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)

Coverage is derived from release 2026-11-21-c8bea25e5abb. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.

Run instructions

No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ctdnalit-20261011-zeng2026-protocol-pe-primary-cv.

Source locator: Results P29; Fig. 4a-b legend; Methods P59-P62

Related records

Suggest a correction